Improvement in Markers of Liver Fibrosis and Function in HCV Genotype 4-Infected Patients with Compensated Cirrhosis Receiving Ombitasvir/Paritaprevir/Ritonavir with Ribavirin (AGATE-I)

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 64; no. 2; p. S826
Main Authors Hassanein, T.I, Asselah, T, Qaqish, R.B, Hezode, C, Mulkay, J.-P, Moreno, C, ElKhashab, M, Alqahtani, S, Yu, Y, Redman, R, Mobashery, N
Format Journal Article
LanguageEnglish
Published 2016
Subjects
Gastroenterology and Hepatology
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
DOI:10.1016/S0168-8278(16)01617-2